Skip to content
November 3, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Advocacy in the Genomic Age: Bridging the Gap Between Scientific Innovation and Federal Policy advocacy-in-the-genomic-age-bridging-the-gap-between-scientific-innovation-and-federal-policy
  • Genomics and Precision Medicine

Advocacy in the Genomic Age: Bridging the Gap Between Scientific Innovation and Federal Policy

Siti Muinah September 28, 2026
Introduction: The Imperative of Scientific Engagement In the rapidly evolving landscape of 21st-century medicine, the translation of...
Read More Read more about Advocacy in the Genomic Age: Bridging the Gap Between Scientific Innovation and Federal Policy
From Public Office to Personal Battle: How One Woman’s Vigilance Saved Her Life from-public-office-to-personal-battle-how-one-womans-vigilance-saved-her-life
  • Survivorship and Post-Treatment

From Public Office to Personal Battle: How One Woman’s Vigilance Saved Her Life

Laily UPN September 28, 2026
Disclaimer: The views expressed in this article are intended for informational purposes only. The National Breast Cancer...
Read More Read more about From Public Office to Personal Battle: How One Woman’s Vigilance Saved Her Life
The Genetic Blueprint of Resilience: Largest Twin Study Unlocks Secrets of Mental Health Susceptibility Legs, toes, feet and heels of newborn twins. Wrapped in a knitted white blanket. Studio macro photography of the legs of newborn twins, close-up white backgraund. Two newborns.
  • Genomics and Precision Medicine

The Genetic Blueprint of Resilience: Largest Twin Study Unlocks Secrets of Mental Health Susceptibility

Raul Delapena Setiawan September 28, 2026
Why do two individuals, exposed to the exact same traumatic event or environmental stressor, walk away with...
Read More Read more about The Genetic Blueprint of Resilience: Largest Twin Study Unlocks Secrets of Mental Health Susceptibility
Roivant Halts Cutaneous Lupus Erythematosus Development for IMVT-1402 Despite Promising Trends, Shifts Focus to Broader Autoimmune Pipeline roivant-halts-cutaneous-lupus-erythematosus-development-for-imvt-1402-despite-promising-trends-shifts-focus-to-broader-autoimmune-pipeline
  • Medical Research and Clinical Trials

Roivant Halts Cutaneous Lupus Erythematosus Development for IMVT-1402 Despite Promising Trends, Shifts Focus to Broader Autoimmune Pipeline

Lina Irawan September 28, 2026
New York, NY – [Insert Date] – Roivant Sciences, a biopharmaceutical company focused on developing and commercializing...
Read More Read more about Roivant Halts Cutaneous Lupus Erythematosus Development for IMVT-1402 Despite Promising Trends, Shifts Focus to Broader Autoimmune Pipeline
The Dawn of the Agentic Era: Schrödinger and BMS Join Forces to Redefine Computational Drug Discovery the-dawn-of-the-agentic-era-schrodinger-and-bms-join-forces-to-redefine-computational-drug-discovery
  • Chemotherapy and Targeted Therapy

The Dawn of the Agentic Era: Schrödinger and BMS Join Forces to Redefine Computational Drug Discovery

Ali Ikhwan September 28, 2026
In a move that signals a seismic shift in pharmaceutical R&D, Schrödinger, the venerable scientific software firm...
Read More Read more about The Dawn of the Agentic Era: Schrödinger and BMS Join Forces to Redefine Computational Drug Discovery
The TrumpRx Paradox: Evaluating the Global Price Parity of U.S. Prescription Drugs the-trumprx-paradox-evaluating-the-global-price-parity-of-u-s-prescription-drugs
  • Breast Cancer Legislation and Policy

The TrumpRx Paradox: Evaluating the Global Price Parity of U.S. Prescription Drugs

Neng Nana September 27, 2026
The quest to lower prescription drug costs for American consumers has long been a central pillar of...
Read More Read more about The TrumpRx Paradox: Evaluating the Global Price Parity of U.S. Prescription Drugs
The Architecture of Connection: Applying Patanjali’s Niyamas to Modern Relationships the-architecture-of-connection-applying-patanjalis-niyamas-to-modern-relationships
  • Integrative Oncology and Holistic Care

The Architecture of Connection: Applying Patanjali’s Niyamas to Modern Relationships

Nana Wu September 27, 2026
Published: September 27, 2026 Subject: Ancient Philosophy and Modern Relational Dynamics In the vast landscape of self-help...
Read More Read more about The Architecture of Connection: Applying Patanjali’s Niyamas to Modern Relationships
Cultivating a New Economy: The BRIDGES Engine Transforms Rural America’s Agricultural Landscape cultivating-a-new-economy-the-bridges-engine-transforms-rural-americas-agricultural-landscape
  • Genomics and Precision Medicine

Cultivating a New Economy: The BRIDGES Engine Transforms Rural America’s Agricultural Landscape

Raul Delapena Setiawan September 27, 2026
In the heart of the American Southeast, a quiet revolution is taking root in the soil of...
Read More Read more about Cultivating a New Economy: The BRIDGES Engine Transforms Rural America’s Agricultural Landscape
Unveiling the Hidden Architects of Risk: Genetics and Treatment Shape Secondary Cancers in Childhood Survivors unveiling-the-hidden-architects-of-risk-genetics-and-treatment-shape-secondary-cancers-in-childhood-survivors
  • Medical Research and Clinical Trials

Unveiling the Hidden Architects of Risk: Genetics and Treatment Shape Secondary Cancers in Childhood Survivors

Muslim September 27, 2026
MEMPHIS, TN – In a landmark study poised to redefine long-term care for childhood cancer survivors, scientists...
Read More Read more about Unveiling the Hidden Architects of Risk: Genetics and Treatment Shape Secondary Cancers in Childhood Survivors
Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine beyond-the-slide-gilead-and-nucleai-challenge-the-limits-of-adc-precision-medicine
  • Treatment Innovations

Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine

Jia Lissa September 27, 2026
The rapid ascent of antibody-drug conjugates (ADCs) has transformed the oncology landscape, offering a high-precision alternative to...
Read More Read more about Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine

Posts pagination

Previous 1 … 222 223 224 225 226 227 228 … 851 Next

Recent Posts

  • Revolutionizing Breast Cancer Screening: A New Era of Personalized Risk Assessment Emerges from the WISDOM Study
  • Breakthrough in ALS Treatment: Zhimeng Biopharma Completes Patient Enrollment for Pivotal CB03-154 Trial
  • Bridging the Gap: How Research and Innovation are Redefining the Breast Cancer Journey in Canada
  • Karyopharm Therapeutics Enters Chapter 11: A Strategic Auction Amidst Financial Crisis
  • FDA Approval of Inovio’s Voceryq: A Landmark for DNA Medicine Amidst Device Scrutiny

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

revolutionizing-breast-cancer-screening-a-new-era-of-personalized-risk-assessment-emerges-from-the-wisdom-study
  • Medical Research and Clinical Trials

Revolutionizing Breast Cancer Screening: A New Era of Personalized Risk Assessment Emerges from the WISDOM Study

Laily UPN November 2, 2026
breakthrough-in-als-treatment-zhimeng-biopharma-completes-patient-enrollment-for-pivotal-cb03-154-trial
  • Medical Research and Clinical Trials

Breakthrough in ALS Treatment: Zhimeng Biopharma Completes Patient Enrollment for Pivotal CB03-154 Trial

Ali Ikhwan November 2, 2026
bridging-the-gap-how-research-and-innovation-are-redefining-the-breast-cancer-journey-in-canada
  • Patient Advocacy and Support

Bridging the Gap: How Research and Innovation are Redefining the Breast Cancer Journey in Canada

Basiran November 2, 2026
karyopharm-therapeutics-enters-chapter-11-a-strategic-auction-amidst-financial-crisis
  • Chemotherapy and Targeted Therapy

Karyopharm Therapeutics Enters Chapter 11: A Strategic Auction Amidst Financial Crisis

Jia Lissa November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.